CSIMarket Company Name, Ticker, Suppliers, else..
 

Haleon Plc  (NYSE: HLN)

Haleon Plc's

Competitiveness



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 

HLN Sales vs. its Competitors Q4 2025


Comparing the current results to its competitors, Haleon Plc reported Revenue increase in the 4 quarter 2025 by 1.35 % year on year.
The sales growth was above Haleon Plc's competitors' average revenue growth of 1 %, achieved in the same quarter.

• List of HLN Competitors

With a net margin of 15.23 % Haleon Plc achieved higher profitability than its competitors.

• More on HLN Profitability Comparisons



Revenue Growth Comparisons




Net Income Comparison

Haleon Plc Net Income in the 4 quarter 2025 grew year on year by 17.56%, while most of its competitors have experienced a contraction in net income by -53.62 %.

<<  HLN Stock Performance Comparisons





  

Overall company Market Share Q4 2025
With modest revenue growth of 1.35 % within Overall company, Haleon Plc increased its market share.


<<  More on HLN Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Haleon Plc




Prestige Consumer Healthcare Inc
Share Performance



-9.68%
Over The Past 5 Days
Prestige Consumer Healthcare Inc
Profile

Prestige Consumer Healthcare Inc operates under a business model focused on acquiring, developing, and marketing branded over-the-counter healthcare products and consumer goods. The company primarily targets niche markets with a strong emphasis on innovation and product quality. Through strategic partnerships and efficient supply chains, Prestige establishes itself as a leader in the healthcare industry, providing accessible and effective solutions to consumers worldwide.

More about Prestige Consumer Healthcare Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 2,246.909 mill. $ 1,104.957 mill. $ 406.272 mill.


Perrigo Company Plc
Share Performance



+0.61%
This Year
Perrigo Company Plc
Profile

Perrigo Company Plc is a leading global healthcare supplier that focuses on providing affordable, high-quality over-the-counter (OTC) healthcare and wellness products. The company operates through its own worldwide distribution network, manufacturing a wide range of products and medications. By leveraging its extensive portfolio and efficient supply chain, Perrigo aims to enhance the well-being of consumers by making quality healthcare products more accessible.

More about Perrigo Company Plc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 1,950.910 mill. $ 4,144.000 mill. $ -1,722.200 mill.

Sources: Haleon Plc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Haleon Plc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.